Similar articles for PMID: 16946559

Year	Number of Results
2000	1
2001	2
2002	4
2003	9
2004	14
2005	16
2006	11
2007	4
2008	11
2009	18
2010	12
2011	15
2012	10
2013	12
2014	7
2015	3
2016	6
2017	4
2018	12
2019	7
2020	12
2021	8
2022	11
2023	4
2024	0

1

Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.

Miyata M, Matsuda Y, Tsuchiya H, Kitada H, Akase T, Shimada M, Nagata K, Gonzalez FJ, Yamazoe Y. Miyata M, et al. Drug Metab Pharmacokinet. 2006 Aug;21(4):315-23. doi: 10.2133/dmpk.21.315. Drug Metab Pharmacokinet. 2006. PMID: 16946559 Free article.

2

Role for enhanced faecal excretion of bile acid in hydroxysteroid sulfotransferase-mediated protection against lithocholic acid-induced liver toxicity.

Miyata M, Watase H, Hori W, Shimada M, Nagata K, Gonzalez FJ, Yamazoe Y. Miyata M, et al. Xenobiotica. 2006 Jul;36(7):631-44. doi: 10.1080/00498250600776827. Xenobiotica. 2006. PMID: 16864508

3

Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.

Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Pineda Torra I, et al. Mol Endocrinol. 2003 Feb;17(2):259-72. doi: 10.1210/me.2002-0120. Mol Endocrinol. 2003. PMID: 12554753

4

Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.

Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, Yamazoe Y. Kitada H, et al. J Biol Chem. 2003 May 16;278(20):17838-44. doi: 10.1074/jbc.M210634200. Epub 2003 Mar 7. J Biol Chem. 2003. PMID: 12637555 Free article.

5

Antiatherosclerotic effect of farnesoid X receptor.

Mencarelli A, Renga B, Distrutti E, Fiorucci S. Mencarelli A, et al. Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H272-81. doi: 10.1152/ajpheart.01075.2008. Epub 2008 Nov 21. Am J Physiol Heart Circ Physiol. 2009. PMID: 19028791 Free article.

6

Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.

Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR. Kim MS, et al. Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E731-8. doi: 10.1152/ajpendo.00130.2004. Epub 2004 Jun 15. Am J Physiol Endocrinol Metab. 2004. PMID: 15198932 Free article.

7

The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.

Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Müller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, Hofker MH, Moore DD. Ricketts ML, et al. Mol Endocrinol. 2007 Jul;21(7):1603-16. doi: 10.1210/me.2007-0133. Epub 2007 Apr 24. Mol Endocrinol. 2007. PMID: 17456796

8

Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.

Hoeke MO, Plass JR, Heegsma J, Geuken M, van Rijsbergen D, Baller JF, Kuipers F, Moshage H, Jansen PL, Faber KN. Hoeke MO, et al. Hepatology. 2009 Jan;49(1):151-9. doi: 10.1002/hep.22661. Hepatology. 2009. PMID: 19111018

9

Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.

Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Li YT, et al. Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2606-11. doi: 10.1161/ATVBAHA.107.152694. Arterioscler Thromb Vasc Biol. 2007. PMID: 18029909

10

Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.

Zhang HM, Wang X, Wu ZH, Liu HL, Chen W, Zhang ZZ, Chen D, Zeng TS. Zhang HM, et al. Mol Med Rep. 2016 Mar;13(3):2135-42. doi: 10.3892/mmr.2016.4761. Epub 2016 Jan 12. Mol Med Rep. 2016. PMID: 26782298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

185 results

Results by year